Alfonso Fasano1, Andres M Lozano. 1. aMorton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital and Division of Neurology, UHN, Division of Neurology bDivision of Neurosurgery, Toronto Western Hospital, University Health Network, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.
Abstract
PURPOSE OF REVIEW: The purpose of this review was to review the recent and future developments of deep brain stimulation (DBS) for movement disorders. RECENT FINDINGS: In the last 2 years, we have gained a better understanding of established indications, particularly with respect to the debate on whether subthalamus or globus pallidus pars interna should be the target of choice for Parkinson's disease. In addition, the role of DBS for dystonia has been further defined in terms of patients' selection and outcome of surgery. Other established (e.g. essential tremor) and novel indications (e.g. Tourette syndrome) have been addressed. Along with the evolving knowledge of the clinical aspects of DBS, technological advances are also shaping the present and the future of DBS. New implantable pulse generators (e.g. allowing storage of electrophysiological data and eventual adaptive stimulation) as well as new electrode configurations are now available. Furthermore, high-resolution structural imaging, including high-field MRI and diffusion tensor tractography, will facilitate both the planning of DBS procedures, and the optimization of postoperative outcomes by aiding stimulation programming. SUMMARY: The recent successes of DBS along the clinical and technological directions are changing the current practice of neuromodulation and, more importantly, will also drive future developments of this fascinating treatment.
PURPOSE OF REVIEW: The purpose of this review was to review the recent and future developments of deep brain stimulation (DBS) for movement disorders. RECENT FINDINGS: In the last 2 years, we have gained a better understanding of established indications, particularly with respect to the debate on whether subthalamus or globus pallidus pars interna should be the target of choice for Parkinson's disease. In addition, the role of DBS for dystonia has been further defined in terms of patients' selection and outcome of surgery. Other established (e.g. essential tremor) and novel indications (e.g. Tourette syndrome) have been addressed. Along with the evolving knowledge of the clinical aspects of DBS, technological advances are also shaping the present and the future of DBS. New implantable pulse generators (e.g. allowing storage of electrophysiological data and eventual adaptive stimulation) as well as new electrode configurations are now available. Furthermore, high-resolution structural imaging, including high-field MRI and diffusion tensor tractography, will facilitate both the planning of DBS procedures, and the optimization of postoperative outcomes by aiding stimulation programming. SUMMARY: The recent successes of DBS along the clinical and technological directions are changing the current practice of neuromodulation and, more importantly, will also drive future developments of this fascinating treatment.
Authors: Paolo Calabresi; Antonio Pisani; John Rothwell; Veronica Ghiglieri; Josè A Obeso; Barbara Picconi Journal: Nat Neurosci Date: 2016-06-28 Impact factor: 24.884
Authors: Y Nagayama; S Tanoue; S Oda; D Sakabe; T Emoto; M Kidoh; H Uetani; A Sasao; T Nakaura; O Ikeda; K Yamada; Y Yamashita Journal: AJNR Am J Neuroradiol Date: 2019-12-26 Impact factor: 3.825
Authors: Gilles de Hollander; Max C Keuken; Wietske van der Zwaag; Birte U Forstmann; Robert Trampel Journal: Hum Brain Mapp Date: 2017-03-27 Impact factor: 5.038
Authors: Gajendra Kumar; Pallavi Asthana; Wing Ho Yung; Kin Ming Kwan; Chung Tin; Chi Him Eddie Ma Journal: Mol Neurobiol Date: 2022-05-17 Impact factor: 5.590
Authors: Alfonso Fasano; Angelo Antonini; Regina Katzenschlager; Paul Krack; Per Odin; Andrew H Evans; Thomas Foltynie; Jens Volkmann; Marcelo Merello Journal: Mov Disord Clin Pract Date: 2020-05-04